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Saccharomonospora sp. UR22 and Dietzia sp. UR66, two actinomycetes derived
from the Red Sea sponge Callyspongia siphonella, were co-cultured and the induced
metabolites were monitored by HPLC-DAD and TLC. Saccharomonosporine A (1),
a novel brominated oxo-indole alkaloid, convolutamydine F (2) along with other
three known induced metabolites (3-5) were isolated from the EtOAc extract of
Saccharomonospora sp. UR22 and Dietzia sp. UR66 co-culture. Additionally, axenic
culture of Saccharomonospora sp. UR22 led to isolation of six known microbial
metabolites (6-11). A kinase inhibition assay results showed that compounds 1 and
3 were potent Pim-1 kinase inhibitors with an IC50 value of 0.3 ± 0.02 and 0.95 ±
0.01 µM, respectively. Docking studies revealed the binding mode of compounds 1
and 3 in the ATP pocket of Pim-1 kinase. Testing of compounds 1 and 3 displayed
significant antiproliferative activity against the human colon adenocarcinoma HT-29, (IC50
3.6 and 3.7µM, respectively) and the human promyelocytic leukemia HL-60, (IC50 2.8
and 4.2µM, respectively). These results suggested that compounds 1 and 3 act as
potential Pim-1 kinase inhibitors that mediate the tumor cell growth inhibitory effect. This
study highlighted the co-cultivation approach as an effective strategy to increase the
chemical diversity of the secondary metabolites hidden in the genomes of the marine
actinomycetes.
Keywords: Saccharomonospora sp., Dietzia sp., actinomycetes, Saccharomonosporine A, convolutamydine F,
docking, Pim-1 kinase, co-cultivation
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INTRODUCTION
Marine sponge-associated microorganisms have been proved an
essential source of biologically active natural products (Thomas
et al., 2010; Roue et al., 2012; Abdelmohsen et al., 2014a).
Large numbers of secondary metabolites with novel molecular
scaffolds and diverse biological activities including antimicrobial
(Hentschel et al., 2001; Eltamany et al., 2014), anti-parasitic
(Abdelmohsen et al., 2014b; Viegelmann et al., 2014),
immunomodulatory (Tabares et al., 2011), and anticancer
(Simmons et al., 2011; Yi-Lei et al., 2014) effects have been
isolated from sponge-associated actinomycetes. For example,
salinosporamide A, a potent inhibitor of the 20S proteasome that
has been isolated from a Salinospora species (Feling et al., 2003;
Gulder and Moore, 2010), entered clinical trials for multiple
myeloma treatment, only three years after its discovery (Fenical
et al., 2009). Due to the continuous discovery of bioactive
natural products from marine microbes, re-isolation of known
microbial secondary metabolites has become a real challenge
(Hong et al., 2009). However, microbial genome sequencing has
confirmed the presence of a large number of silent biosynthetic
gene clusters that encode for secondary metabolites which are
not produced under normal laboratory conditions (Dashti et al.,
2014). Microbial competition for nutrition and other resources
is considered one of the most important factors for induction of
novel bioactive secondary metabolites (Oh et al., 2005). Crosstalk
between microbes inhabiting the same environment induces
the unexpressed biosynthetic pathways leading to production of
unusual secondary metabolites (Pettit, 2009; Schroeckh et al.,
2009; Zuck et al., 2011). Co-cultivation of two different microbial
strains together in one culture allows direct interaction between
them, which may lead to the induction of new cryptic secondary
metabolites not previously detected in the axenic cultures (Rateb
et al., 2013). Examples of the production of induced new natural
products by co-fermentation of marine derived microorganisms
include a rare class of pseurotins, 11-O-methylpseurotin A2
derived from mixed fermentation of Streptomyces bullii and the
fungus Aspergillus fumigatus MBC-F1-10 (Rateb et al., 2013),
the cyclic depsipeptides emericellamides A and B isolated from
a co-culture of marine-derived fungus Emericella sp. (CNL-878)
and the marine bacterium Salinispora arenicola (Oh et al.,
2007), the diterpenoids libertellenones A–D isolated from mixed
fermentation of the marine α-proteobacterium strain CNJ-328
with the fungus and Libertella sp. CNL-52 (Oh et al., 2005)
and a chlorinated benzophenone pestalone sourced from a
co-culture of the same bacterial strain CNJ-328 with Pestalotia
sp. strain (Cueto et al., 2001). Recently, co-culture has also
proved that both strains affect each other and induce new fungal
and bacterial metabolites which were not detected in axenic
cultures (Wakefield et al., 2017). In this study, we report on the
induction of new bioactive secondary metabolites (Figure 1)
saccharomonosporine A (1) and convolutamydine F (2) along
with other three known metabolites 3-5 in response to microbial
co-cultivation of two marine actinomycetes, Saccharomonospora
sp. UR22 and Dietzia sp. UR66, derived from the Red Sea sponge
Callyspongia siphonella. The HPLC and TLC chromatograms of
the axenic cultures together with the co-culture derived extracts
showed that compounds 1-5 were produced only during co-
fermentation of both microbes. On the other hand, fermentation
of Saccharomonospora sp. UR22 alone led to the isolation of
a set of known microbial metabolites (6-11). Performing in
vitro assay and docking studies on the isolated compounds
revealed the potential of Pim-1 kinase as a promising target for
only compound 1 and 3. Cytotoxicity evaluation of the isolated
compounds showed that compound 1 and 3 have significant
antiproliferative activities against HT-29 and HL-60 cell lines.
These results coincide with the enzyme inhibition assay ones.
MATERIAL AND METHODS
General Apparatus and Chemicals
Ultra violet (UV) spectra were acquired on a ultra-violet visible
(UV-vis) spectrometer (Shimadzu UV 1800 spectro, Japan).
Optical rotation values were acquired at Bellingham + Stanley
ADP600 Series Polarimeter at the sodium D line (589 nm)
and 25◦C. IR spectra were recorded as KBr disks on a IR
spectrophotometer (Shimadzu S8400, Japan) High performance
liquid chromatography (HPLC) analysis was performed by
Thermofisher dionex ultimate 3000 with PDA detector and
Xterra (Waters) C18 RP analytical HPLC column (5µm, 4.6 ×
250mm). High resolutionmass spectrometric data were obtained
using a Thermo Instruments MS system (LTQ XL/LTQ Orbitrap
Discovery) coupled to a Thermo Instruments HPLC system
(Accela PDA detector, Accela PDA autosampler, and Accela
pump). 1D and 2D NMR spectra were recorded on Bruker
Avance III 400 MHz (Bruker AG, Switzerland) with BBFO Smart
Probe and Bruker 400 AEON Nitrogen-Free Magnet. Data were
analyzed using Topspin 3.1 Software. Each sample was dissolved
in suitable deuterated solvent. Chemical shifts were recorded
and expressed in ppm related to the TMS signal at 0.00 ppm as
internal reference. All solvent used for preparing extracts were
of technical grade (ADWIC; El-Nasr Pharmaceutical Chemicals
Co., Egypt); and reagents used for preparing samples were of
analytical grade (E-Merck, Darmstadt, Germany). Silica gel (60–
120 mesh, 50 g, Fluka R©) was used for chromatographic isolation
and purification. TLC analysis was performed using Merck 9385
pre-coated aluminum plate silica gel (Kieselgel 60) with F254
indicator thin layer plates.
Isolation and Cultivation of the
Actinomycetes
Callyspongia siphonella was collected at a depth of 10m
in the Red Sea (Hurghada, Egypt) in November 2015. A
voucher specimen was reserved at the National Institute of
Oceanography and Fisheries, Red Sea Branch, Invertebrates
Department. Sponge biomass was transferred to plastic bag
containing seawater and transported to the laboratory. Sponge
specimens were rinsed in sterile seawater, cut into pieces of
ca. 1 cm3, and then thoroughly homogenized in a sterile
mortar with 10 volumes of sterile seawater. The supernatant was
diluted in ten-fold series (10−1, 10−2, 10−3) and subsequently
plated out on agar plates. Five different media M1 (Mincer
et al., 2002), ISP2 medium (Shirling and Gottlieb, 1966),
oligotrophic medium (OLIGO) (Olson et al., 2000), actinomycete
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FIGURE 1 | Structures of isolated compounds.
isolation agar (AIA) (Lechevalier and Lechevalier, 1975) and
marine agar (MA) (Weiner et al., 1985) were used for the
isolation of actinomycetes. All media were supplemented with
0.2µm pore size filtered cycloheximide (100µg/mL), nystatin
(25µg/mL), and nalidixic acid (25µg/mL) to facilitate the
isolation of slow-growing actinomycetes. Cycloheximide and
nystatin inhibit fungal growth, while nalidixic acid inhibits
many fast-growing Gram-negative bacteria. All media contained
DifcoBacto agar (18 g/L) and were prepared in 1 L artificial
sea water (NaCl 234.7 g, MgCl2.6 H2O 106.4 g, Na2SO4 39.2 g,
CaCl2 11.0 g, NaHCO3 1.92 g, KCl 6.64 g, KBr 0.96 g, H3BO3
0.26 g, SrCl2 0,24 g, NaF 0.03 g, and ddH2O to 10.0 L) (Lyman
and Fleming, 1940). The inoculated plates were incubated
at 30◦C for 6–8 weeks. Distinct colony morphotypes were
picked and re-streaked until visually free of contaminants.
Saccharomonospora sp. UR22 and Dietzia sp. UR66 were
cultivated on ISP2 medium. The isolates were maintained on
plates for short-term storage and long-term strain collections
were set up in medium supplemented with 30% glycerol at
−80◦C.
Molecular Identification
16S rRNA gene amplification, cloning and sequencing were
performed according to Hentschel et al. using the universal
primers 27F and 1492R (Lane, 1991). Chimeric sequences
were identified by using the Pintail program (Ashelford et al.,
2005). The genus-level affiliation of the sequence was validated
using the Ribosomal Database Project Classifier. The genus-
level identification of all the sequences was done with RDP
Classifier (-g 16srrna, -f allrank) and validated with the SILVA
Incremental Aligner (SINA) (search and classify option) (Pruesse
et al., 2012). An alignment was calculated again using the
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SINAweb aligner (variability profile: bacteria). Gap-only position
were removed with trimAL (-noallgaps). For phylogenetic tree
construction, the best fitting model was estimated initially with
Model Generator. RAxML (-f a -m GTRGAMMA –x 12345
–p 12345 –# 1000) and the estimated model was used with
1,000 bootstrap resamples to generate the maximum-likelihood
tree. Visualization was done with Interactive Tree of Life
(ITOL).
Fermentation, Extraction, and Isolation
Each strain was fermented in 10 Erlenmeyer flasks (2 L), each
containing 1 L of ISP 2 (International Streptomyces Project)
medium in artificial sea water and incubated at 30◦C for 14
days with shaking at 150 rpm. For co-cultivation experiment,
10mL of 5-day-old culture of Saccharomonospora sp. UR22 was
inoculated into 15 Erlenmeyer flasks (2 L), each containing 1 L
of ISP 2 medium inoculated with 10mL of 5-day-old culture of
FIGURE 2 | HPLC profiles of actinomycetes extracts. (A) Saccharomonospora sp. UR22 and Dietzia sp. UR66 co-culture (B) Saccharomonospora sp. UR22
mono-culture (C) Dietzia sp. UR66 mono-culture.
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Dietziasp. UR66. After fermentation of single cultures and co-
culture, filtration was done, and the supernatant was extracted
with ethyl acetate (3 × 500mL) to give the ethyl acetate extracts.
These extracts (400mg for Saccharomonospora sp. UR22, 950mg
for co-culture) were fractionated on a Sephadex LH20 (32-
64µm, 100 x 25mm, Fluka R©) column eluting with MeOH/H2O
(90:10%), to yield six fractions. Fraction Nr. 2 (from co-culture)
was subjected to C18 reversed-phase column chromatography
(0.04–0.063mm, 50× 10mm, Merck R©) with an isocratic elution
using acetonitrile/water (40:60) to give five crude compounds
1-5. Further purification was performed by preparative TLC
on a (20 cm × 20 cm) silica gel plates that developed in
CH2Cl2/MeOH/NH3 (7:4:0.5, v/v) solvent system. Fraction Nr.
4 (from Saccharomonospora sp. UR22) was treated in the same
manner to obtain six known compounds 6-11 (Figure 1).
HPLC Analysis
All actinomycete-derived extracts were analyzed by HPLC-DAD.
Fifty micro liters (1 mg/mL in acetonitrile) of bacterial crude
extracts was injected. Then, isocratic elution was performed
with 50% aqueous acetonitrile containing 0.1% trifluoroacetic as
amobile phase over 15min at a flow rate of 1 mL/min and UV
detection at different wavelengths (210, 254, 270, and 300 nm).
Pim-1 Kinase Assay
The kinase activity was measured following the manufacturer’s
instructions (HTScan Kinase Assays from Cell Signaling
TABLE 1 | 1H (400 MHz) and 13C NMR (100 MHz) data for
saccharomonosporine A (1) in DMSO-d6.
Position δH, mult.
(J in Hz)
δC Type COSY HMBC NOESY
1-NH 7.98, br s C-3a, C-2
2 168.8 C
3 143 C
3a 122.6 C
4 8.12, d, (8.8) 127.9 CH H-5 C-6, C-3, C-7a H-17
5 7.75, dd,
(8.8, 2)
130 CH H-4 C-6
6 123.7 C
7 8.2, d, (2) 131.1 CH
7a 149.3 C
8 7.96, s 118.2 CH C-3a, C-9, C-2 H-10
9 157.4 C
10 7.37, d,
(16.4)
126 CH H-11 C-8, C-12, C-9 H-13, H-8
11 7.88, d,
(16.4)
136 CH H-10 C-13, C-9
12 129 C
13 7.73, d, (8.8) 129.5 CH H-14 C-11, C-15 H-10
14 7.03, d, (8.8) 114.9 CH H-13 C-13, C-15, C-12 H-16
15 160.6 C
16 3.81, s 55.7 CH3 C-15 H-14
17-NH 8.3, br s H-4
Technology) using staurosporine as a positive control. Different
concentrations of test compounds were incubated with 50 ng of
Pim-1 kinase enzyme in the reaction buffer [25mMTris–HCl pH
7.5, 10mM MgCl2, 0.1mM Na3VO4, 5 mM–glycerophosphate,
2mM dithiothreitol (DTT)] and the ATP/substrate cocktail
[200µM ATP + 1.5µM biotinylated BAD Ser112 peptide]
at room temperature for 30min. The reaction was stopped
by the addition of stop buffer (50mM EDTA, pH 8) and
transferred to a streptavidincoated 96-well plate. After incubation
for 1 h at room temperature, the wells were washed three
times with phosphate-buffered saline Tween-20 (PBST) buffer.
After incubation with anti BADSer112 antibody for 2 h,
the wells were washed three times with 1 × PBST and
incubated with the peroxidase-conjugated secondary antibody
for 30min. Following three washes with 1 × PBST, the substrate
(3,3,5,5-tetramethylbenzidine) was added and the samples were
incubated at room temperature for 15min. The reaction was
stopped by the addition of 2N HCl and the absorbance was
measured with a spectrophotometer at 450 nm. The assay was
performed in triplicate.
Docking Studies
The crystal structure of Pim-1 of PDB code 3umw was used.
Docking experiments were conducted employing LigandFit
docking engine. This docking software considers the ligand
as flexible and the receptor as rigid structure. The binding
site was generated from the “Find sites as volume of selected
ligands” option in Discovery Studio 2.5. The number of trials of
Monte Carlo search parameters = 30,000; and search step for
torsions with polar hydrogens = 30.0◦. The root mean square
threshold for ligand-to-binding-site shape matching was set to
2.0 Å, employing a maximum of 1.0 binding-site partitions.
The interaction energies were assessed employing the CFF force
field (v.1.02) with a non-bonded cutoff distance of 10.0 Å
and distance-dependent dielectric. An energy grid extending
5.0 Å from the binding site was implemented. The interaction
energy was estimated with a trilinear interpolation value
using soft potential energy approximations. Rigid body ligand
minimization parameters: 40 steepest descent iterations followed
by the 80 Broyden–Fletcher–Goldfarb–Shannon minimization
iterations were applied to every orientation of the docked ligand.
The proposed inhibitors were further energy minimized within
the binding site by implementing the “Smart Minimization”
option for a maximum of 1,000 iterations (Khanfar and Taha,
2013).
MTT Assay
Cell proliferation was evaluated in cell lines by the MTT assay
in triplicates. 104 cells were plated in a 96-well microtiter plate
in a final volume of 100 µl of culture medium. Cells were
treated for 24 h with test compound at 37 ◦C with 5% CO2.
After treatment, the cells were immediately incubated with 10
µl MTT (5.0 mg/mL) for 4 h at 37◦C. The cells were then lysed
in 100 µl of lysis buffer (isopropanol, conc. HCl and Triton X-
100) for 10min at room temperature and 300 rpm/min shaking.
The enzymatic reduction of MTT to formazan crystals that
dissolved in DMSO was quantified by photometry at 570 nm.
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Dose-response curves were generated and the IC50 values were
define d as the concentration of compound required to inhibit
cell proliferation by 50%. 5-Flurouracil was used as a positive
control.
RESULTS AND DISCUSSION
Mono and Co-culture HPLC Profiles
HPLC and TLC analysis of EtOAc extracts obtained from
axenic fermentation of each actinomycete compared to that
from mixed fermentation indicated a very different chemical
profiles (Figure 2). The co-culture derived extract showed a
higher metabolic diversity than extracts from mono cultures.
Exclusive detection ofmetabolites 1-5 in the co-culture illustrated
that they are produced only upon co-fermentation of the two
microbes.
Isolation and Structural Characterization
Guided by HPLC-DAD, the EtOAc extracts from the liquid
cultures of the axenic fermentations and mixed fermentation
were subjected to Sephadex LH-20 column chromatography
followed by C18 reversed-phase column chromatography and
final preparative TLC purification to target the isolation of the
new metabolites 1 and 2 together with the other nine known
metabolites 3-11. Compound 1was isolated as yellow amorphous
powder. The molecular formula C19H15O2N2Br was suggested
on the basis of positive HRESIMS ion atm/z 383.0392 [M+H]+,
indicating 13 degrees of unsaturation. Furthermore, the presence
of a bromine atom was confirmed by its characteristic isotope
cluster (Figure S1). 1H NMR spectral data of 1 (Figure S2)
(Table 1) in DMSO-d6 suggested the presence of a methyl
singlet at δH 3.81 (3H, s, H-16) and two exchangeable protons
(δH 8.32, 7.98) due to NH. The splitting pattern of resonances
at δH 8.20 (H-7), 8.12 (H-4), and 7.75 (H-5) together with
the COSY correlation (Figure S5) between (H-4) and (H-5)
suggested the presence of a 1,3,4-trisubstituted benzene ring.
On the other hand, the signals at δH 7.73 (H-13), 7.03 (H-14)
and the 1H-1H COSY correlation between them indicated
TABLE 2 | 1H (400 MHz) and 13C NMR (100 MHz) data for 2 in DMSO-d6.
Position δH, mult. (J in Hz) δC Type COSY HMBC
1-NH 10.37, br s - C-2, C-3a
2 - 178.0 C
3 - 72.3 C
3a - 131.0 C
4 7.19, d, (9) 125.5 CH H-5 C-6, C-3, C-3a
5 7.09, dd, (9, 2) 123.8 CH H-4
6 - 121.6 C
7 6.93, d, (2) 112.3 CH
7a - 144.4 C
8 3.05, d, (18) 50.0 CH2 C-9, C-3a, C-2
3.33, d, (18)
9 - 205.3 C
10 2.0, s 30.4 CH3 C-9, C-8
11-OH 6.07, br s -
FIGURE 3 | 1H-1H COSY, key HMBC, and NOESY correlations of compound (1).
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the presence of 1,4 disubstituted benzene ring. The DEPTQ
spectrum (Figure S3) (Table 1) displayed seventeen signals,
with eight sp2 aromatic carbons including eight CH groups
and six quaternary carbons, and one sp3 aliphatic carbon (CH3
group). The spectra also revealed an aminocarbonyl at δC168.8
(C-2), an imino carbon at δC 157.4 (C-9) and one oxygenated
carbon at δC 55.7 (C-16). The assignment of protonated carbons
was achieved by the HSQC data (Figure S4). The key HMBC
correlations (Figure S6) from H-4 (δH 8.12) to C-3 (δC 143),
and from the exchangeable proton H-1(δH 7.98) to the carbonyl
carbons C-2 (δC 168.8) and C-3a (δC 122.6) together with the
previous reported data (Guo et al., 2010) suggested the presence
of brominated indolin-2-one skeleton at C-6 (δC 123.7). The
sub-structure of a methoxyphenyl group was deduced from the
HMBC correlation between the methyl protons H-16 (δH 3.81)
and C-15 (δC 160.6). 1H-1H COSY correlation between H-11
(δH 7.88) and H-10 (δH 7.37) together with HMBC correlations
from H-11 to C-10 (δC 126) and C-9 (δC 157.4), from H-10
to C-9 and C-8 (δC 118.2) indicated the presence of an imino
butenylidene moiety. The E configuration of H-11 (δH 7.88, d)
and H-10 (δH 7.37, d) was deduced from the J-values extracted
from the 1H NMR spectrum (J = 16.4 Hz). The connection of
the imino butenylidene moiety to the methoxyphenyl group was
established through the HMBC correlation from H-13 (δH 7.73)
to C-11 (δC 136). Moreover, the HMBC correlations (Figure 3)
from H-8 (δH 7.96) to C-2 (δC 168.8) and C-3a (δC 122.6)
connected this moiety to the indolin-2-one skeleton at C-3. The
chemical shifts of H-8 at δH 7.96 and H-4 at δH 8.12 are very
characteristic for E configuration at the double bond between
C-3 and C-9 (Faita et al., 1994). Furthermore, NOESY correlation
(Figures S7, S8) between the NH proton H-17 and H-4, and
absence of NOESY cross-peak betweenH-8 andH-4, also pointed
to the E configuration at the C-3/C-8 double bond. On that
basis, the structure of 1 was established as (E)-6-bromo-3-((E)-2-
imino-4-(4-methoxyphenyl)but-3-en-1-ylidene)indolin-2-one,
FIGURE 4 | 1H-1H COSY, key HMBC, and NOESY correlations of compound
(2).
a new secondary metabolite to which were named as
Saccharomonosporine A.
Compound 2 was isolated as white crystals, the molecular
formula C11H10O3NBr was suggested on the basis of positive
HRESIMS ion at m/z 283.9899 [M+H]+, indicating seven
degrees of unsaturation. Furthermore, the presence of a
bromine atom was confirmed by its characteristic isotope cluster
(Figure S9). Similar to compound 1, the 1H and 13C NMR
spectra (Figures S10, S11) of 2 (Table 2) also revealed an
aminocarbonyl at δC178.0 and one oxygenated carbon at δC 72.3
(C-3). The key HMBC correlations (Figure 4 and Figure S14)
from H-4 (δH 7.19) to C-3 (δC 72.3), and from the exchangeable
proton H-1(δH 10.37) to the carbonyl carbons C-2 (δC 178) and
C-3a (δC 131) together with the previous reported data (Guo
et al., 2010) suggested the presence of brominated indolin-2-
one skeleton. A 2-oxopropyl unit was deduced from the HMBC
cross-peaks of H-8 (δH 3.05) to C-9 (δC 205.3), H-10 (δH 2.0)
to C-8 (δC 50), and H-10 to C-9 and was indicated to be
attached at C-3 (δC 72.3) through the HMBC correlation of
H-8 to C-3. These spectroscopic data together with the optical
rotation value [α]25D –13.8 (c 0.85, MeOH), revealed that this
compound is the previously unreported (S) enantiomer of (R)-
6-Bromo-3-hydroxy-3-(2 oxopropyl)indolin-2-one, a synthetic
3-hydroxyoxindole derivative (Guo et al., 2010). Several 3-
hydroxyoxindole derivatives have been reported from natural
marine sources (Kamano et al., 1995; Zhang et al., 1995). For
example, convolutamydine A, a brominated (R) enantiomer of
2 (Kamano et al., 1995), so the name convolutamydine F was
suggested to compound 2.
Compound 3 was isolated as white crystals. HRESIMS, 1D
and 2D NMR spectral data (Table S1, Figures S15–S20) revealed
that compound 3 has a planer structure identical to compound
3f, a previously reported synthetic intermediate (Wang and Ji,
2006), which obtained as a racemic mixture. Compound 3 had a
negative optical rotation of [α]25D −8.7 (c 0.3, MeOH), in contrast
to previous reports on similar optically active compounds that
showed a positive optical rotations for the (R) enantiomers
(Deng et al., 2010; Guo et al., 2010). On this basis compound
3 was identified as (S) 6-bromo-3-hydroxy-3-(1H-indol-3-yl)
TABLE 3 | In-vitro Pim-1 kinase inhibitory activity of isolated metabolites.
Tested Compound IC50 ± S.D. (µM)
a
1 0.3 ± 0.02
2 >20
3 0.97 ± 0.01
4 >20
5 >20
6 >20
7 >20
8 >20
9 >20
10 >20
11 >20
Staurosporine 0.04 ± 0.01
aValues are a mean of 3 independent experiments.
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FIGURE 5 | Docking of compounds 1 (A,B) and 3 (C,D) within the ATP-binding site of Pim-1 kinase (PDB code 3umw). (E,F) The key binding interactions of Pim-1
co-crystallized ligand. The amino acid side chains were depicted in (A,C,E) for clarification.
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indolin-2-one. To the best of our knowledge, compounds 2
and 3 are considered the first (S) 3-hydroxyoxindole derivatives
reported from natural sources. Nonactin (4) (Wu and Sun, 2006)
and vibrindole (5) (Ronit et al., 1994) were also isolated from
the co-culture of Saccharomonospora sp. UR22 and Dietzia sp.
UR66. In addition, indole-3-carbaldehyde (6) (Ashour et al.,
2007), tryptophol (7) (Gore et al., 2012), indole-3-pyruvic acid
(8) (Wishart et al., 2007), skatole (9) (Chen et al., 2015),
1-hydroxy-2-naphthoic acid (10) (Kauko and Lajunen, 1978)
and 1,4 dihydroxy-2-naphthoic acid (11) (Isawa et al., 2002)
were isolated from the axenic culture of Saccharomonospora
sp. UR22. All isolated known metabolites were identified based
on their accurate mass analyses and comparison of their NMR
spectroscopic data (Figures S21–S28) with those reported in the
literature.
Pim-1 Kinase Assay
Pim-1 kinase is a well-established oncoprotein in several tumor
entities, e.g., myeloid leukemia, prostate cancer, colorectal cancer,
or pancreatic cancer (Weirauch et al., 2013). In addition, over
expression of Pim-1 kinase has been described in both human
colon adenocarcinoma HT-29 cell (Weirauch et al., 2013) and
human promyelocytic leukemia HL-60 (Fan et al., 2016) cell
lines. Treatment of the aforementioned cell lines with Pim-1
kinase inhibitors resulted in a potent growth inhibitory activity
(Weirauch et al., 2013; Fan et al., 2016). Furthermore, previous
compounds structurally similar to compounds 1 and 3 showed
potent and selective Pim-1 kinase inhibitory activity (Nakano
et al., 2012; Sun et al., 2015). In order to investigate Pim-1 kinase
as a potential target that mediates tumor cell growth inhibitory
effect, all isolated compounds were evaluated for their efficacy to
inhibit the in vitro enzymatic activity of Pim-1 kinase (Table 3).
Compounds 1 and 3 exhibited significant inhibitory effects on
Pim-1 enzyme activity with an IC50 value of 0.3 ± 0.02 and 0.95
± 0.01µM, respectively.
Docking of the Active Compounds
The potential binding mode of compounds 1 and 3 with Pim-
1 kinase was analyzed by docking in the ATP-binding site of
Pim-1. The protein data bank (PDB) contains several Pim-1
crystallographic proteins, however, Pim-1 of PDB code (3umw)
was selected for docking experiments since it has optimum
resolution (2.08 Å) and is co-crystalized with Pim-1 inhibitor
that is structurally similar to compound 1 and 3 (Nakano et al.,
2012). The sphere surrounding the co-crystallized inhibitor was
selected as an active site for docking. Both compounds 1 and
3 showed similar docking poses (Figure 5) and comparable
to the co-crystalized inhibitor (Nakano et al., 2012). The
bromobenzene moiety of compound 1 is impeded within a
hydrophobic pocket of ALA65, LEU44, VAL126, and LEU175.
The oxindole proton of amidic group is interacted with the
hinge region through hydrogen bonding to the main chain
carbonyl of GLU121. Hydrogen bonding of this nature was
reported with several Pim-1 inhibitors (Nakano et al., 2012).
Moreover, the oxindole carbonyl oxygen is hydrogen bonded to
the peptidic proton of ASP186 bridged through the conserved
water molecule (HOH30). The imine nitrogen of compound 1
is hydrogen bonded to the terminal amino moiety of LYS67. The
phenoxy ring is sandwiched between two hydrophobic surfaces
of PHE49 and VAL52 (Figure 5A). Alternatively, compound
3 share similar interactions as in compound 1 within the
hydrophobic pocket of ALA65, LEU44, VAL126, and LEU175,
and hydrogen bonding interaction with GLU121 and ASP186.
Moreover, the indole nitrogen is hydrogen bonded with peptidic
oxygen of ILE185. However, the interaction with LYS67 is
a pi-cation interaction with the indole ring of compound 3
(Figure 5C). The binding interactions of compounds 1 and 3
showed high resemblance with the binding mode of the co-
crystalized ligand (PDB code: 3umw) within the ATP-binding
site of Pim-1 (Nakano et al., 2012). The co-crystalized structure
forms similar hydrogen bonding interactions (with GLU121
and LYS67), hydrophobic interactions (with LEU174, VAL126,
LEU44, VAL52, and ALA65), and pi-stacking (with PHE49)
as with compounds 1 and 3 (Figure 5E). However, the co-
crystalized ligand forms additional electrostatically-enforced
hydrogen bonding interaction with ASP128. Such interaction can
explain the superior activity of the co-crystalized ligand (IC50
= 3 nM) over compounds 1 and 3. Therefore, the electrostatic
interaction with ASP128 should be taking into consideration for
future designing of more active analogs of compounds 1 and 3.
Antiproliferative Activity
The antiproliferative properties of the nine isolated compounds
were evaluated against lung adenocarcinoma H1650, the
human promyelocytic leukemia HL-60 and the human colon
adenocarcinoma HT-29 cell lines (Table 4). Compounds 1 and
3 displayed potent antiproliferative activity against HL-60 and
HT-29 cells (IC50 2.8, 3.6 and 4.2, 3.7µM, respectively). The
other compounds did not exhibit any cytotoxicity at the tested
concentrations. These results came in great accordance with the
Pim-1 kinase assay results.
Data for Saccharomonosporine A (1)
Yellow powder (18mg); UV (MeOH) λmax (log ε) 343 (4.22), 425
(3.16); IR (KBr) νmax 3165, 1716, 1605, 1570, cm−1; 1H-NMR
TABLE 4 | Antiproliferative activity of isolated metabolites against H1650, HL-60,
and HT-29 cancer cells.
Tested Compounds IC50 ± S.D. (µM)
a
H1650 HL-6 HT-29
1 >100 2.8 ± 0.74 3.6 ± 0.55
2 >100 >100 >100
3 >100 4.2 ± 0.23 3.7 ± 0.31
4 >100 >100 >100
5 >100 >100 >100
6 >100 >100 >100
7 >100 >100 >100
8 >100 >100 >100
9 >100 >100 >100
10 >100 >100 >100
11 >100 >100 >100
5-Flurouracil 0.5 ± 0.67 0.2 ± 0.43 0.3 ± 0.35
aValues are a mean of 3 independent experiments.
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(DMSO-d6, 400 MHz); and 13C-NMR (DMSO-d6, 100 MHz)
data, see Table 1; HRESIMS m/z 383.0392 [M + H]+ (calcd for
C19H15O2N2Br).
Data for Convolutamydine F (2)
White crystals (10mg); UV (MeOH) λmax (log ε) 323 (3.18),
408 (2.83); [α]25D –13.8 (c 0.85, MeOH), IR (KBr) νmax 3331,
1742, 1714 cm−1; 1H-NMR (DMSO-d6, 400MHz) and 13C-NMR
(DMSO-d6, 100 MHz) data, see Table 2; HRESIMSm/z 283.9899
[M+H]+ (calcd for C11H10O3NBr).
CONCLUSION
In this study, two sponge-derived actinomycetes,
Saccharomonospora sp. UR22 and Dietzia sp. UR66, were co-
fermented in liquid media. The presence of induced metabolites
was studied by comparison of the HPLC-DAD and TLC
chromatograms of the crude extracts of the two axenic cultures
and the co-culture. Co-cultivation of Saccharomonospora sp.
UR22 and Dietzia sp. UR66 induced the biosynthesis of novel
oxindole alkaloid saccharomonosporine A (1), convolutamydine
F (2) along with other three induced metabolites (3-5) which
were not detected in either microorganism in a single culture.
Axenic culture of Saccharomonospora sp. UR22 led to isolation of
common known microbial metabolites 6-11. Compounds 1 and
3 exhibited potent antiproliferative activities toward HL-60 and
HT-29. Based on previous reports on similar compounds, Pim-1
inhibitory assay results and docking studies in the ATP-binding
site of Pim-1 kinase, we suggested that both compounds 1 and
3 mediated their cytotoxicity by inhibiting the well-known
oncoprotein Pim-1 kinase. These findings highlighted the
co-cultivation approach as an effective strategy to enhance the
chemical diversity of the secondary metabolites hidden in the
genomes of the marine actinomycetes.
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